Lataa...
Recent advances in transthyretin amyloidosis therapy
Mutant (MT) forms of transthyretin (TTR) cause the most common type of autosomal-dominant hereditary systemic amyloidosis—familial amyloidotic polyneuropathy (FAP). Until 20 years ago, FAP was thought to be an endemic disease, but FAP is known to occur worldwide. To date, more than 130 mutations in...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4165622/ https://ncbi.nlm.nih.gov/pubmed/25228988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-9158-3-19 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|